Smith & Nephew plc (LON:SN) fell 1% during mid-day trading on Thursday . The company traded as low as GBX 1,309 ($17.62) and last traded at GBX 1,310 ($17.63). 2,642,030 shares traded hands during trading, a decline of 9% from the average session volume of 2,900,000 shares. The stock had previously closed at GBX 1,322.89 ($17.80).
A number of brokerages have issued reports on SN. Berenberg Bank reissued a “hold” rating and set a GBX 1,340 ($18.03) target price on shares of Smith & Nephew in a report on Friday, November 3rd. J P Morgan Chase & Co reaffirmed a “neutral” rating and issued a GBX 1,382 ($18.60) price target on shares of Smith & Nephew in a report on Monday, November 6th. Deutsche Bank upped their price target on shares of Smith & Nephew from GBX 1,200 ($16.15) to GBX 1,315 ($17.70) and gave the stock a “hold” rating in a report on Monday, October 23rd. Jefferies Group reaffirmed a “buy” rating and issued a GBX 1,515 ($20.39) price target on shares of Smith & Nephew in a report on Thursday, October 12th. Finally, Citigroup reaffirmed a “sell” rating and issued a GBX 1,160 ($15.61) price target on shares of Smith & Nephew in a report on Thursday, October 12th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of GBX 1,315.82 ($17.71).
About Smith & Nephew
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
What are top analysts saying about Smith & Nephew plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Smith & Nephew plc and related companies.